Fortress Biotech, Inc. - Significant Ownership

Signature - Title
/s/ Lindsay A. Rosenwald - Lindsay A. Rosenwald, M.D. / Chairman, President and Chief Executive Officer
Location
Bay Harbor Islands, FL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Fortress Biotech, Inc..

Significant Ownership of Fortress Biotech, Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MBIO Mustang Bio, Inc. Common Stock, $0.0001 Par Value 12.4% $1.71M 6.57M Fortress Biotech, Inc. Dec 31, 2024
ATXI Avenue Therapeutics, Inc. Common Stock, $0.0001 Par Value 10.3% $108K $11.1K 329K +11.4% Fortress Biotech, Inc. Mar 31, 2025
MBIO Mustang Bio, Inc. Common Stock, $0.0001 Par Value 4% $427K $98.5K 259K +30% Fortress Biotech, Inc. Sep 29, 2025
CKPT Checkpoint Therapeutics, Inc. Common Stock, $0.0001 Par Value 0% $0 -$28.8M 0 -100% Fortress Biotech, Inc. May 30, 2025

Schedules 13D/G Reported by Fortress Biotech, Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.